English

This webpage discusses how using doxycycline as STI PEP (post-exposure prophylaxis) is a new use for a well-known medication. Learn more about this new tool and how it's being used to prevent STIs!

This guide provides clinical and programmatic advice to program managers and frontline health workers on the bi-directional screening of TB and diabetes mellitus. The resource also includes information on the management and treatment of patients with TB and diabetes mellitus. 

This video provides information for patients and family members within Navajo Nation about tuberculosis. The video specifically discusses what tuberculosis is, how it is transmitted, and how it is successfully treated. 

This is video provides an introduction about tuberculosis infection and tuberculosis disease and how TB is tested for and treated.

Use the images and suggested messaging below to help educate Californians about the importance of reducing the spread of mpox and staying up to date on mpox vaccination. Feel free to share via social media platforms, websites, patient portals, emails, and other ways to reach your audiences.

This video discusses how most vaccines offer you a level of protections, just like sunblock. Sometimes you need to reapply for more protection. The Mpox vaccine is based on two shots several weeks apart to provide you with the strongest level of protection if you are exposed to Mpox. You only need the two dose Mpox vaccination for Mpox to get strongest recommended protection. 

This fact sheet from Virginia Department of Health provides basic information on mpox.

This recorded presentation delves into the critical issue of STI disparities among adolescents in the Southern United States, a pressing public health concern with significant implications for health equity. Understanding these disparities is essential for developing effective interventions and policies to promote the well-being of marginalized communities. 

This video from World Hepatitis Alliances highlights youth voices and a discussion on viral hepatitis and HIV.

This webpage discusses how viral hepatitis disproportionately impacts Hispanic/Latinx communities. In 2018, Hispanic/Latinx individuals were 1.4 times more likely to die from Hepatitis C than non-Hispanic whites, with significant barriers such as language, access to care, and high-risk behaviors contributing to these disparities. Despite the availability of effective treatments, Hispanic/Latinx patients face significant treatment gaps. Social determinants of health, such as lower insurance coverage and limited access to quality care, exacerbate these issues.